Ensuring the integrity of container closure systems (CCS) is critical for the safety and efficacy of high-risk drug products. This whitepaper explores the regulatory landscape, key testing methods, and risk-based approaches required to qualify CCS for parenteral and ophthalmic applications. Drawing on Nelson Labs’ expertise in extractables, leachables, and integrity testing, it provides a practical roadmap for achieving compliance while protecting patient safety.
Learn more about the authors below.
